Wave Life Sciences WVE Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $602.07M+99.3% | $302.08M+50.8% | $200.35M+126% | $88.5M-41.2% | ||
| $3.81M+1.2% | $3.76M+1.6% | $3.7M+1.1% | $3.66M+0.2% | ||
| $1.28M-10.3% | $1.42M-93.3% | $21.09M— | —— | ||
| $614.81M+91.9% | $320.39M+36.1% | $235.37M+139% | $98.54M-39.4% | ||
| $7.41M-26.9% | $10.13M-22.6% | $13.08M-24.3% | $17.28M-22.4% | ||
| $12.46M-30.3% | $17.87M-21.1% | $22.64M-15.7% | $26.84M+46.1% | ||
| $16K-70.9% | $55K-64.7% | $156K+152% | $62K-58.1% | ||
| $23.69M-25.5% | $31.81M-19.6% | $39.58M-17.3% | $47.85M+7.7% | ||
| $638.5M+81.3% | $352.21M+28.1% | $274.95M+87.8% | $146.39M-29.3% | ||
| $15.7M-3.5% | $16.26M+26.7% | $12.84M-24.1% | $16.92M+132% | ||
| $26.56M+26.0% | $21.08M+25.3% | $16.83M-4.1% | $17.55M+18.1% | ||
| $44.44M-32.6% | $65.97M-56.0% | $150.06M+376% | $31.56M-14.9% | ||
| $8.36M+9.5% | $7.64M+13.8% | $6.71M+22.2% | $5.5M+10.8% | ||
| $7.8M+27.9% | $6.1M-60.9% | $15.6M-80.4% | $79.77M+3.0% | ||
| $95.07M-14.3% | $110.95M-40.5% | $186.44M+161% | $71.52M+11.4% | ||
| $9.41M-47.1% | $17.77M-30.1% | $25.4M-20.9% | $32.12M+28.7% | ||
| $17.2M-27.9% | $23.87M-41.8% | $41.01M-63.4% | $112.08M+9.4% | ||
| $112.27M-16.7% | $134.82M-40.7% | $227.45M+23.9% | $183.6M+10.2% | ||
| $1.62B+37.6% | $1.18B+25.6% | $935.37M+16.5% | $802.83M+7.1% | ||
| $228.37M+46.0% | $156.45M+21.1% | $129.24M+8.2% | $119.44M+35.8% | ||
| -$1.33B-18.2% | -$1.12B-9.5% | -$1.02B-5.9% | -$967.34M-20.1% | ||
| -$250K+4.6% | -$262K-111% | -$124K-328% | -$29K-116% | ||
| $518.36M+147% | $209.52M+429% | $39.63M+188% | -$45.09M-239% | ||
| $638.5M+81.3% | $352.21M+28.1% | $274.95M+87.8% | $146.39M-29.3% | ||
| $3.08M-58.2% | $7.35M+82.7% | $4.02M+90.9% | $2.11M-61.1% | ||
| $16K-70.9% | $55K-64.7% | $156K— | —— | ||
| $12.46M-30.3% | $17.87M-21.1% | $22.64M-15.7% | $26.84M+46.1% | ||
| $12.46M-30.3% | $17.87M-21.1% | $22.64M-15.7% | $26.84M+46.1% | ||
| $16K-70.9% | $55K-64.7% | $156K— | —— | ||
| $12.46M-30.3% | $17.87M-21.1% | $22.64M-15.7% | $26.84M+46.1% | ||
| $16K-70.9% | $55K-64.7% | $156K— | —— | ||
| $7.8M+27.9% | $6.1M-60.9% | $15.6M-80.4% | $79.77M+3.0% | ||
| $7.8M+27.9% | $6.1M-60.9% | $15.6M-80.4% | $79.77M+3.0% | ||
| $26.56M+26.0% | $21.08M+25.3% | $16.83M-4.1% | $17.55M+18.1% | ||
| $7.8M+27.9% | $6.1M-60.9% | $15.6M-80.4% | $79.77M+3.0% | ||
| $17.77M-30.1% | $25.4M-20.9% | $32.12M-14.6% | $37.61M+25.7% | ||
| $1.62B+37.6% | $1.18B+25.6% | $935.37M+16.5% | $802.83M+7.1% | ||
| $8.4M-12.0% | $9.54M-3.7% | $9.91M+25.0% | $7.93M+20.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Wave Life Sciences's total assets?
- Wave Life Sciences (WVE) holds $583.5M in total assets, up 102.4% year over year.
- How much debt does Wave Life Sciences have?
- Wave Life Sciences carries $15.7M in total debt against $511.7M of shareholders' equity, a debt-to-equity ratio of 0.03.
- How much cash does Wave Life Sciences have?
- Wave Life Sciences holds $544.6M in cash and equivalents.
- Can Wave Life Sciences cover its short-term obligations?
- Its current ratio is 11.26 — current assets exceed current liabilities.
- Where does Wave Life Sciences's balance sheet data come from?
- Every line is extracted from Wave Life Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
